Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001896023 | SCV002151797 | pathogenic | Orofacial-digital syndrome IV; Joubert syndrome 18 | 2021-11-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with TCTN3-related conditions. This variant is present in population databases (rs779729881, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Gly237Aspfs*12) in the TCTN3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TCTN3 are known to be pathogenic (PMID: 2692869, 22883145, 25118024). |
Fulgent Genetics, |
RCV001896023 | SCV005678469 | likely pathogenic | Orofacial-digital syndrome IV; Joubert syndrome 18 | 2024-05-14 | criteria provided, single submitter | clinical testing |